1 tion, are low to submicromolar inhibitors of beta-N-acetylhexosaminidases.

2  Sfhex is an ortholog of mammalian lysosomal beta-N-acetylhexosaminidases.

3 s that Sfhex may play a role as a processing beta-N-acetylhexosaminidase acting on N-glycans from Sf9

4                  Digestion of MS11mkC LOS by beta-N-acetylhexosaminidase and beta-galactosidase, alon

5 (IC50 value) and chaperoning efficacy toward beta-N-acetylhexosaminidase, derivatives of the compound

6                            Finally, although beta-N-acetylhexosaminidase digestion dramatically inhib

7 d and qualified after beta-galactosidase and beta-N-acetylhexosaminidase digestion.

8              We report the purification of a beta-N-acetylhexosaminidase from the culture medium of S

9                                              beta-N-Acetylhexosaminidase inhibition by an azetidine A

10                                   However, a beta-N-acetylhexosaminidase responsible for the generati

11 ve disorders due to defects in the lysosomal beta-N-acetylhexosaminidase system.

12                       beta-Galactosidase and beta-N-acetylhexosaminidase were used to convert complex